Rhythm or rate control in atrial fibrillation—Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial
Top Cited Papers
- 1 November 2000
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 356 (9244), 1789-1794
- https://doi.org/10.1016/s0140-6736(00)03230-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Atrial fibrillation: current knowledge and recommendations for management*1European Heart Journal, 1998
- Atrial Fibrillation: Maintaining Stability of Sinus Rbythm or Ventricular Rate Control? The Need for Prospective Data: The PIAF TrialPacing and Clinical Electrophysiology, 1997
- Atrial fibrillation: Maintenance of sinus rhythm versus rate controlThe American Journal of Cardiology, 1996
- Proarrhythmia with Class III Antiarrhythmic Drugs: Definition, Electrophysiologic Mechanisms, Incidence, Predisposing Factors, and Clinical ImplicationsJournal of Cardiovascular Electrophysiology, 1995
- Functional capacity before and after cardioversion of atrial fibrillation: a controlled study.Heart, 1994
- Indications and Limitations of Class II and III Antiarrhythmic Drugs in Atrial FibrillationPacing and Clinical Electrophysiology, 1994
- The MOS 36-Item Short-Form Health Survey (SF-36)Medical Care, 1993
- Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: A transtelephonic monitoring studyAmerican Heart Journal, 1992
- Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamilJournal of the American College of Cardiology, 1990
- The effect of cardioversion on maximal exercise capacity in patients with chronic atrial fibrillationAmerican Heart Journal, 1989